| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 49 |
| 1 | MACITENTAN | 41 |
| 2 | FOSCARBIDOPA/FOSLEVODOPA | 35 |
| 3 | EPOPROSTENOL | 32 |
| 4 | TADALAFIL | 32 |
| 5 | SILDENAFIL CITRATE | 31 |
| 6 | SILDENAFIL | 24 |
| 7 | 0XYGEN | 19 |
| 8 | OXYGEN | 19 |
| 9 | AMBRISENTAN | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 35 | 0.0040 |
| 1 | EPOPROSTENOL | 32 | 0.0024 |
| 2 | GOLODIRSEN | 1 | 0.0020 |
| 3 | PROCHLORPERAZINE EDISYLATE | 2 | 0.0017 |
| 4 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 5 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 6 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 7 | MIDODRINE HYDROCHLORIDE | 3 | 0.0007 |
| 8 | MACITENTAN | 41 | 0.0006 |
| 9 | DOBUTAMINE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 80 |
| 1 | Endothelin Receptor Antagonist [EPC] | 54 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 44 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 4 | Loop Diuretic [EPC] | 19 |
| 5 | Osmotic Laxative [EPC] | 19 |
| 6 | Aldosterone Antagonist [EPC] | 14 |
| 7 | Benzodiazepine [EPC] | 14 |
| 8 | Corticosteroid [EPC] | 13 |
| 9 | Aromatic Amino Acid [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 80 | 0.0006 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 10 | 0.0004 |
| 2 | Barbiturate [EPC] | 4 | 0.0003 |
| 3 | Sigma-1 Agonist [EPC] | 3 | 0.0003 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 44 | 0.0003 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 11 | 0.0003 |
| 6 | Cholinesterase Inhibitor [EPC] | 6 | 0.0003 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 8 | 0.0003 |
| 8 | Endothelin Receptor Antagonist [EPC] | 54 | 0.0003 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |